Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Innocan Pharma Corp (INNPF)

Innocan Pharma Corp (INNPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Innocan Pharma Secures Patent for LPT-CBD in Japan, Strengthening Global IP Portfolio

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. InnoCan Pharma...

INNPF : 4.4600 (-9.90%)
Innocan Pharma Partners With a Sanctuary For Injured Animals to Bring Remedy and Hope with its LPT-CBD injection

HERZLIYA, Israel and CALGARY, AB , Sept. 18, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in...

INNO : 17.72 (+0.57%)
INNPF : 4.4600 (-9.90%)
Innocan Pharma Partners With a Sanctuary For Injured Animals to Bring Remedy and Hope with its LPT-CBD injection

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology...

INNO.CN : 6.5000 (unch)
INNPF : 4.4600 (-9.90%)
Innocan Pharma's Poster on its Liposomal Synthetic CBD Technology Generates Interest at PAINWeek Conference

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology...

INNO.CN : 6.5000 (unch)
INNPF : 4.4600 (-9.90%)
Innocan Pharma's Poster on its Liposomal Synthetic CBD Technology Generates Interest at PAINWeek Conference

HERZLIYA, Israel and CALGARY, Alberta , Sept. 15, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer...

INNO : 17.72 (+0.57%)
INNPF : 4.4600 (-9.90%)
Innocan Pharma Announces Details of Proposed Share Consolidation

HERZLIYA, Israel and CALGARY, Alberta , Aug. 29, 2025 /PRNewswire/ -- Innocan Pharma Corporation (" Innocan " or the " Company ") (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)...

INNO : 17.72 (+0.57%)
INNPF : 4.4600 (-9.90%)
Innocan Pharma Announces Details of Proposed Share Consolidation

/CNW/ -- Innocan Pharma Corporation ("Innocan" or the "Company") (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to announce that further to its press release...

INNO.CN : 6.5000 (unch)
INNPF : 4.4600 (-9.90%)
Innocan Pharma Announces First Half Of 2025 Financial Results

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on...

INNO.CN : 6.5000 (unch)
INNPF : 4.4600 (-9.90%)
Innocan Pharma Announces First Half Of 2025 Financial Results

HERZLIYA, Israel and CALGARY, AB , Aug. 27, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the " Company " or " Innocan "), a...

INNO : 17.72 (+0.57%)
INNPF : 4.4600 (-9.90%)
Innocan's Findings to be Showcased in Scientific Poster Reception at PAINWeek 2025 Conference in Las Vegas, Nevada

HERZLIYA, Israel and CALGARY, AB , Aug. 22, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer...

INNO : 17.72 (+0.57%)
INNPF : 4.4600 (-9.90%)

Barchart Exclusives

This Dividend Stock Is Becoming Too Cheap to Ignore: Should You Buy?
Disney has a dividend of 1.5% and trades at a discount to the markets as well as its historical valuations. The stock looks like a good buy, particularly for value investors. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.